WebBLUEDOT BIO LLC is a Delaware Domestic Limited-Liability Company filed on September 27, 2024. The company's filing status is listed as Active and its File Number is 6262068. … WebNaveen K. Jain (/ n ɒ ˈ v iː n dʒ eɪ n /; born September 6, 1959) is an Indian-American business executive, entrepreneur, and the founder and former CEO of InfoSpace.InfoSpace briefly became one of the largest internet companies in the American Northwest, before the crash of the dot-com bubble and a series of lawsuits involving Jain. In 2010 Jain co …
Better public health surveillance for infectious diseases
WebApr 28, 2024 · With this honor, AFCR, Bluedot Bio, and other new investors contributed $7.5 million of new capital, joining Chimera’s existing investors, including Viking Global Investors, Founders Fund, and Illumina Accelerator, to bring the company’s total amount raised to $26 million, since the company was founded in 2015. WebBluedot Bio is a biotechnology company producing first-in-class drugs and platform technologies for prevalent diseases, including cancer. Bluedot Bio’s unique platform … Bluedot Bio was founded by a group of scientists, business experts and … Bluedot Bio is determined to stop cancer maintenance and progression by … Our platform technology is applicable for treating numerous diseases Pipeline … Bluedot Bio believes that science is a collaborative venture and that the … [email protected]. About us; Technology; Pipeline; Portfolio; Contact … logarithm product property
Bluedot Bio Inc - YouTube
WebAug 7, 2024 · TORONTO, August 7, 2024 /PRNewswire/ - BlueDot, a digital health company that uses big data analytics to track and anticipate the spread of the world's most dangerous infectious diseases, announced today that it has closed a $7M (USD) Series A financing round co-led by The Co-operators and BDC Capital's Women in Technology … WebMar 1, 2024 · Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: D.E.J. and J.R.G. are co-inventors of cyclic STAT3 decoy and have financial interests in Bluedot Bio. Bluedot Bio has licensed patents related to cyclic STAT3 decoy. WebApr 28, 2024 · AFCR’s BRACE Award is a first-of-its-kind program for early stage oncology technology companies focused on Asian-prevalent cancers. With this honor, AFCR, Bluedot Bio, and other new investors contributed $7.5 million of new capital, joining Chimera’s existing investors, including Viking Global Investors, Founders Fund, and Illumina … induction versus gas cooktop